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Nonrandom X-Chromosome Inactivation in
Hemopoietic Cells from Carriers of Dyskeratosis
Congenita
To the Editor:
Dyskeratosis congenita (DC) is a rare inherited ectoder-
mal dysplasia characterized by dermatologic manifesta-
tions and nail dystrophy. Bone-marrow failure has been
reported to occur in Ç50% of cases (Dokal 1996), and
in some patients symptoms related to aplastic anemia
may precede the diagnosis of DC (Forni et al. 1993).
The gene for the X-linked recessive form of DC has
been assigned to Xq28 by X chromosome–speciﬁc
RFLPs (Connor et al. 1986; Arngrimsson et al. 1993;
Knight et al. 1996), but the primary defect responsible
for the disease is still unknown. Existing methods for
carrier detection therefore rely on analysis of genetic
linkage and are limited both by the availability of sam-
ples from adequate pedigrees and by the degree of poly-
Figure 1 Analysis of family A. a, Pedigree (asterisks indicatemorphism of closely linked markers within a kindred.
women tested for X-chromosome inactivation). b, AR-methylationMore recently, in vitro clonogenic assays, as well as
PCR assay. The DNA was predigested with (lanes denoted ‘‘/’’) and
long-term bone marrow–culture studies have suggested without (lanes denoted ‘‘0’’) the methylation-sensitive enzyme HpaII;
that symptoms of aplastic anemia in DC might be due each allele is represented by two bands. Lanes 1 and 2, PMN from
II-1. Lanes 3 and 4, MNC from subject II-1. Lanes 5 and 6, PMNto a defect at the level of the hematopoietic stem cell
from II-7. Lanes 7 and 8, MNC from II-7. Lanes 9 and 10, PMN(Marsh et al. 1992). For this reason, we hypothesized
from III-7. Lanes 11 and 12, MNC from III-7. Absence of the lowerthat, at least in some DC families, the selective pressure
allele in the ‘‘/’’ lanes indicates nonrandom X-chromosome inactiva-
in the heterozygote might be strong enough to determine tion.
negative selection of progenitors bearing the mutant al-
lele, resulting in extreme skewing of X-chromosome in-
activation in cells of hemopoietic descent. Selection DNA was extracted and puriﬁed according to routine
procedures. X–inactivation analysis was performed byagainst cells bearing the mutant allele has been demon-
strated in heterozygotes for several X-linked disorders taking advantage of the favorable characteristics of het-
erozygosity at the X-linked human androgen receptor(Belmont 1996), especially immunodeﬁciencies (Gealy
et al. 1980; Conley et al. 1986), and in such families (AR) locus—namely, the high percentage of informative
subjects, the advantage of a PCR assay, and the consis-assessment of randomness of X-chromosome inactiva-
tion has been successfully used to test for carrier status tent pattern of methylation of HpaII and HhaI sites
within a highly polymorphic CAG repeat in the coding(Puck et al. 1987).
We examined two kindreds in which the probands region of the ﬁrst exon of the AR gene (Allen et al.
1992). The details of the PCR analysis, run in the pres-had been found to have DC after severe symptoms of
bone-marrow failure had developed, in order to evaluate ence of a radioactive nucleotide, have been described
elsewhere (Willman et al. 1994; Ferraris et al. 1997).X–inactivation mosaicism in hemopoietic cells from ob-
ligate carriers and other female members of the family. Visual assessment of relative hybridization intensities by
inspection of the autoradiographs was conﬁrmed byCriteria for diagnosis of DC were the ﬁndings of nail
dystrophy, reticulate hyperpigmented skin lesions, oral quantitation of the two AR alleles, by comparison of
radioactive intensity of the bands by means of a densi-leukoplakia, and severe pancytopenia in the probands.
Both examination of the pedigrees (ﬁgs. 1 and 2) and tometer. All assays were performed in duplicate, with
the assayer blinded to the identity of the samples.linkage analysis (Knight et al. 1996) were consistent
with an X-linked recessive disorder in both families. Sixteen women, seven of them from family A and nine
of them from family B, were investigated after informedWhole blood leukocytes (WBC), granulocytes (PMN),
and mononuclear cells (MNC) were isolated according consent was obtained (table 1). The DNA of all subjects
was extracted from WBC. In addition, puriﬁed fractionsto standard methods; the purity of hemopoietic cell pop-
ulations was evaluated by direct examination of cytocen- of PMN and MNC were isolated from all obligate carri-
ers (two from family A and two from family B) andtrifuged slides stained with May-Gru¨nwald-Giemsa.
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In family A the two obligate carriers were found to
have nonrandom X-chromosome inactivation in their
PMN and MNC, whereas all other subjects tested, in-
cluding the sister of the propositus, exhibited a balanced
pattern of X-chromosome inactivation (table 1). A sam-
ple of the results obtained with the PCR ampliﬁcation
of the AR gene from this kindred is shown in the lower
part of ﬁgure 1.
In the second family, the mothers of the two affected
boys also expressed nonrandom use of the X chromo-
some in their hemopoietic cells; of the two sisters of a
proband, one was found to have nonrandom X-chromo-
some inactivation and the other exhibited a random pat-
tern of X-chromosome inactivation (table 1). In the
lower half of ﬁgure 2 are compared the results of X–
inactivation analysis performed on PMN from one obli-
gate carrier, who was nonrandomly inactivated, and the
results obtained on one of her daughters, who had ran-
dom inactivation of the X chromosome. Although only
a few examples are shown here, these results are repre-
sentative of our ﬁndings on other females studied, both
Figure 2 Analysis of family B. a, Pedigree (asterisks [*] indicate from within these two pedigrees and from other sources
subjects tested for X-chromosome inactivation). b, Representative (Ferraris et al. 1997).
PCR AR assays (details of test are as in ﬁg. 1). Panel 1 shows selective
Subject IV-6 from this pedigree is the only individualuse of a single X chromosome as the active one in PMN cells from
from the two families who has a skewed X–inactivationIII-7; panel 2 shows random X-chromosome inactivation in PMN
from IV-5. pattern and a prior probability of being a carrier of .5.
After being tested, she might be correctly identiﬁed as a
carrier, in which case the conditional probability is 1.0,
but she might simply be skewed on a chance basis, withfrom four other females (one from family A and three
from family B) of unknown carrier status (table 1). a conditional probability of .075, since, on the basis of
All women were informative at the AR locus, thus
conﬁrming both reports by others (Naumova et al.
1996) and our own experience (164 [89%] heterozygous
Table 1
women, of 185 screened so far) of the very high percent-
X-Chromosome Inactivation in Women from Two DC Familiesage of polymorphism with this marker. Artiﬁcial mix-
tures made of DNA from control women homozygous
Family and Subject Cell Populations Pattern offor alleles with different numbers of CAG repeats in
(Age [years]) Tested X Inactivationa
the AR gene showed that identiﬁcation of the minor
component was unequivocal when it constituted §5% A:
II-1 (51) WBC, PMN, MNC Nonrandomof the total (Ferraris et al. 1997; A. M. Ferraris, unpub-
II-3 (48) WBC Randomlished data). In our control set of AR heterozygotes,
II-5 (46) WBC Randomthe allelic ratio after HpaII digestion was found to be
II-7 (44) WBC, PMN, MNC Nonrandom
consistent with random X-chromosome inactivation in III-7 (23) WBC, PMN, MNC Randomú90% (49 of 53) of the women tested. Therefore, if III-9 (20) WBC Random
III-12 (16) WBC Randomwe consider those unrelated women whom we sampled
B:speciﬁcally as a control group, only 7.5% of them had
II-3 (65) WBC Randomú95% of their blood cells with the same X chromosome
III-4 (47) WBC Random
active. The results of our analysis of X–inactivation pat- III-7 (40) WBC, PMN, MNC Nonrandom
terns in normal females are in full accordance with those III-9 (37) WBC, PMN, MNC Nonrandom
III-11 (35) WBC, PMN, MNC Randomreported by other investigators (Busque et al. 1996;
IV-1 (28) WBC RandomNaumova et al. 1996). Consequently, it can be safely
IV-2 (27) WBC Randomstated that excessive skewing, deﬁned as §95% expres-
IV-5 (17 WBC, PMN, MNC Random
sion of one X-linked allele, is an infrequent event in IV-6 (8) WBC, PMN, MNC Nonrandom
healthy women without a family history of a genetic
a Nonrandom X inactivation is ú90:10.disorder.
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our data, 7.5% of normal women have ú95% of their ﬁrmatory comprehensive investigation of the pattern of
X-chromosome inactivation in various hemopoietic cellsblood cells with the same X chromosome active. The
joint probability of being correctly identiﬁed as a carrier of women from two large DC families. We have ob-
served selective inactivation phenomena in the PMN andwould then be .5 (.5 1 1), whereas the joint probability
of being a skewed noncarrier would be .0375 (.5 MNC of obligate carriers, implying that the DC gene
defect is expressed in each of these cell populations.1 .075). Therefore, the probability of being correctly
identiﬁed as a carrier would be .93 [.5/(.5 / .0375)]. To the extent that tissue-speciﬁc selective inactivation
reﬂects the primary cell target(s) of the gene defect, theThis constraint should be explained carefully to any pro-
spective consultand in a similar situation. analysis of X–inactivation pattern should help to deter-
mine the cellular and molecular bases for DC, as hasOur conclusion is that obligate-carrier status, as deter-
mined by disease segregation, was correlated with a pat- been the case for other X-linked disorders, thereby pro-
viding an additional step toward identiﬁcation of thetern of nonrandom X-chromosome inactivation in every
case. Moreover, selective inactivation of the X chromo- gene(s) involved.
some occurs within several hemopoietic cell populations
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To the Editor: zygous for all markers tested, and the child inherited
only one allele for each marker, resulting in homozygos-We read with great interest the recent report by Bernas-
coni et al. (1996) describing a case of maternal isodi- ity for both chromosome arms, consistent with isochro-
mosomes. The ﬁnding of true isochromosomes in oursomy 2 due to the de novo inheritance of two isochromo-
somes for chromosome 2. We recently identiﬁed an case and in that reported by Bernasconi et al. (1996)
most likely formed through misdivision of the centro-additional case of maternal isodisomy 2 also caused by
the de novo inheritance of two isochromosomes for mere in a monosomy-2 conceptus. Other possibilities, as
discussed elsewhere (Bernasconi et al. 1996), also exist.chromosome 2. However, in our case, the child has some
signiﬁcant features that are in common with recently In sharp contrast to the case presented by Bernasconi
et al., in which there were no apparent phenotypic ab-reported cases of maternal disomy 2 (Bernard et al.
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